Release Date: 31/08/16 18:53 Summary: Ceasing to be a substantial holder-BRB.AX Price Sensitive: No Download Document 170.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%